Pharma boss warns 'UK life sciences in crisis' as industry discontent grows

There is no shortage of criticism currently being directed at the UK government from the public sector, especially where healthcare is concerned.

But if the pharmaceutical industry is anything to go by, there is also increasing disquiet in the private sector, too, with a growing list of firms expressing dissatisfaction at policies, revenue clawbacks and a perceived lack of investment into innovation.

AbbVie, Lilly and BMS losing patience